‘I want medical tourism to be open to everyone, forever’
BioViva's CEO Liz Parrish on de-risking regulatory systems and creating evidence-based medicine from medical tourism.
Most Popular
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Researchers at the University of Alabama to investigate the effects of microbiome disruption on Alzheimer’s disease progression.
Will psychedelics produce the next longevity drug?
Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.
New study reveals how neurons die in Alzheimer’s disease
Breakthrough research illustrates how neurons initiate a programmed form of cell death – and how neuron death can be prevented.
Leveraging the past to illuminate longevity for the future
Rooted in Amish genetic knowledge, Zoe Biosciences’ novel platform could become the gold standard for delayed human aging.
Supplements
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Partnership aims to set a new standard for health and wellness in the United Arab Emirates.
Editor's pick
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Researchers at the University of Alabama to investigate the effects of microbiome disruption on Alzheimer’s disease progression.
Crucible Therapeutics spins out with £5m for neurodegenerative disease gene therapies
Gene therapy company emerges with £5 million ($6.1 million) in funding to target neurodegenerative disease.
Vivante gobbles up $31m for digestive health tech
Digital digestive health company concludes a $31 million Series B funding round to advance its gut health platform GIThrive.
‘We are information machines – and it’s time to renew the code.’
Methuselah Foundation's CEO David Gobel on clinging to the longevity biotech mast while waiting for the rising tide.
Watch now
‘I want medical tourism to be open to everyone, forever’
BioViva's CEO Liz Parrish on de-risking regulatory systems and creating evidence-based medicine from medical tourism.
Physicians want AI tech to help dementia patients live longer
Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
